Literature DB >> 3024722

The role of sphingomyelin synthetase and sphingomyelinase in 1,2-dimethylhydrazine-induced lipid alterations of rat colonic plasma membranes.

P K Dudeja, R Dahiya, T A Brasitus.   

Abstract

Recently, our laboratory, utilizing the 1,2-dimethylhydrazine model of colonic adenocarcinoma, demonstrated alterations in the 'dynamic component' of fluidity in brush-border membranes prepared from distal colonocytes of rats administered this agent for 5, 10 and 15 weeks, i.e., before the development of colon cancer. Furthermore, changes in the sphingomyelin content and sphingomyelin/phosphatidylcholine molar ratio of these membranes appeared, at least partially, to be responsible for these fluidity alterations. In an attempt to elucidate the mechanism(s) involved in these dimethylhydrazine-induced lipid changes, in the present studies the activities of sphingomyelin synthetase and magnesium-dependent neutral sphingomyelinase, enzymes involved in the synthesis and degradation of this phospholipid, respectively, were examined and compared in distal colonic brush-border membranes prepared from rats after 5, 10 or 15 weeks administration of dimethylhydrazine or diluent. The results of these studies demonstrate that alterations in both these enzymatic activities can be detected after administration of dimethylhydrazine and appear to, at least in part, be responsible for the changes in membrane sphingomyelin composition noted previously. These results as well as a discussion of their possible serve as the basis for the present report.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024722     DOI: 10.1016/0005-2736(86)90272-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Effects of ursodeoxycholate and other bile salts on levels of rat intestinal alkaline sphingomyelinase: a potential implication in tumorigenesis.

Authors:  R D Duan; Y Cheng; H D Tauschel; A Nilsson
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

2.  Effect of dietary fat on phospholipid class distribution and fatty acid composition in rat fat cell plasma membrane.

Authors:  K L Khuu Thi-Dinh; Y Demarne; C Nicolas; C Lhuillery
Journal:  Lipids       Date:  1990-05       Impact factor: 1.880

3.  VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation.

Authors:  I Soo; K L Madsen; Q Tejpar; B C Sydora; R Sherbaniuk; B Cinque; L Di Marzio; M Grazia Cifone; C Desimone; R N Fedorak
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

4.  Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopy.

Authors:  T E Merchant; J N Kasimos; P W de Graaf; B D Minsky; L W Gierke; T Glonek
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

Review 5.  Sphingolipids in colon cancer.

Authors:  Mónica García-Barros; Nicolas Coant; Jean-Philip Truman; Ashley J Snider; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-09-21

6.  Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells.

Authors:  Erik Hertervig; Ake Nilsson; Yajun Cheng; Rui-Dong Duan
Journal:  J Cancer Res Clin Oncol       Date:  2003-08-12       Impact factor: 4.553

7.  Distribution of alkaline sphingomyelinase activity in human beings and animals. Tissue and species differences.

Authors:  R D Duan; E Hertervig; L Nyberg; T Hauge; B Sternby; J Lillienau; A Farooqi; A Nilsson
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

8.  Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation?

Authors:  E Hertervig; A Nilsson; J Björk; R Hultkrantz; R D Duan
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

9.  Sphingolipid metabolism in colorectal adenomas varies depending on histological architecture of polyps and grade of nuclear dysplasia.

Authors:  Krzysztof Kurek; Bartłomiej Łukaszuk; Agnieszka Świdnicka-Siergiejko; Paweł Rogalski; Eugeniusz Wróblewski; Adrian Chabowski; Andrzej Dąbrowski; Małgorzata Żendzian-Piotrowska
Journal:  Lipids       Date:  2015-01-17       Impact factor: 1.880

Review 10.  Metabolism, physiological role, and clinical implications of sphingolipids in gastrointestinal tract.

Authors:  Krzysztof Kurek; Bartłomiej Łukaszuk; Dominika M Piotrowska; Patrycja Wiesiołek; Anna Małgorzata Chabowska; Małgorzata Zendzian-Piotrowska
Journal:  Biomed Res Int       Date:  2013-09-05       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.